181 related articles for article (PubMed ID: 21464578)
1. Changes of the Retina and Intrinsic Survival Signals in a Rat Model of Glaucoma following Brinzolamide and Travoprost Treatments.
Park HY; Kim JH; Lee DE; Lee JH; Park CK
Ophthalmic Res; 2011 Oct; 46(4):208-17. PubMed ID: 21464578
[TBL] [Abstract][Full Text] [Related]
2. Intraocular pressure lowering, change of antiapoptotic molecule expression, and neuroretinal changes by dorzolamide 2%/timolol 0.5% combination in a chronic ocular hypertension rat model.
Park HY; Lee NY; Kim JH; Park CK
J Ocul Pharmacol Ther; 2008 Dec; 24(6):563-71. PubMed ID: 19049297
[TBL] [Abstract][Full Text] [Related]
3. [Adjunctive therapy with brinzolamide in patients on travoprost treatment].
Babić N; Andreić V; Miljković A; Canadanović V; Barisić S
Med Pregl; 2011; 64(5-6):310-4. PubMed ID: 21789924
[TBL] [Abstract][Full Text] [Related]
4. Alteration of retinal intrinsic survival signal and effect of alpha2-adrenergic receptor agonist in the retina of the chronic ocular hypertension rat.
Kim HS; Chang YI; Kim JH; Park CK
Vis Neurosci; 2007; 24(2):127-39. PubMed ID: 17640403
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
[TBL] [Abstract][Full Text] [Related]
6. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
[TBL] [Abstract][Full Text] [Related]
7. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
Katz G; Dubiner H; Samples J; Vold S; Sall K
JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
[TBL] [Abstract][Full Text] [Related]
8. Diabetes has an additive effect on neural apoptosis in rat retina with chronically elevated intraocular pressure.
Kanamori A; Nakamura M; Mukuno H; Maeda H; Negi A
Curr Eye Res; 2004 Jan; 28(1):47-54. PubMed ID: 14704913
[TBL] [Abstract][Full Text] [Related]
9. α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension.
Wang X; Su J; Ding J; Han S; Ma W; Luo H; Hughes G; Meng Z; Yin Y; Wang Y; Li J
Drug Des Devel Ther; 2016; 10():3449-3457. PubMed ID: 27799744
[TBL] [Abstract][Full Text] [Related]
10. Intraocular pressure reduction with travoprost/timolol fixed combination, with and without adjunctive brinzolamide, in glaucoma.
Holló G; Kóthy P
Curr Med Res Opin; 2008 Jun; 24(6):1755-61. PubMed ID: 18479590
[TBL] [Abstract][Full Text] [Related]
11. Blocking LINGO-1 function promotes retinal ganglion cell survival following ocular hypertension and optic nerve transection.
Fu QL; Hu B; Wu W; Pepinsky RB; Mi S; So KF
Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):975-85. PubMed ID: 18326721
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats.
Zhang XY; Xiao YQ; Zhang Y; Ye W
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3912-21. PubMed ID: 23557740
[TBL] [Abstract][Full Text] [Related]
13. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
Holló G; Bozkurt B; Irkec M
Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
[TBL] [Abstract][Full Text] [Related]
14. Akt is activated via insulin/IGF-1 receptor in rat retina with episcleral vein cauterization.
Kanamori A; Nakamura M; Nakanishi Y; Nagai A; Mukuno H; Yamada Y; Negi A
Brain Res; 2004 Oct; 1022(1-2):195-204. PubMed ID: 15353229
[TBL] [Abstract][Full Text] [Related]
15. Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy.
Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC;
J Glaucoma; 2012 Jan; 21(1):55-9. PubMed ID: 21048504
[TBL] [Abstract][Full Text] [Related]
16. Comparing the effects of travoprost and brinzolamide on intraocular pressure after phacoemulsification.
Ermis SS; Ozturk F; Inan UU
Eye (Lond); 2005 Mar; 19(3):303-7. PubMed ID: 15258611
[TBL] [Abstract][Full Text] [Related]
17. Expression of leukemia inhibitory factor in the rat retina following acute ocular hypertension.
Hu Q; Huang C; Wang Y; Wu R
Mol Med Rep; 2015 Nov; 12(5):6577-83. PubMed ID: 26352383
[TBL] [Abstract][Full Text] [Related]
18. Detection of early neuron degeneration and accompanying glial responses in the visual pathway in a rat model of acute intraocular hypertension.
Zhang S; Wang H; Lu Q; Qing G; Wang N; Wang Y; Li S; Yang D; Yan F
Brain Res; 2009 Dec; 1303():131-43. PubMed ID: 19765568
[TBL] [Abstract][Full Text] [Related]
19. Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.
McKinnon SJ; Lehman DM; Kerrigan-Baumrind LA; Merges CA; Pease ME; Kerrigan DF; Ransom NL; Tahzib NG; Reitsamer HA; Levkovitch-Verbin H; Quigley HA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1077-87. PubMed ID: 11923249
[TBL] [Abstract][Full Text] [Related]
20. Topical carbonic anhydrase inhibitors and visual function in glaucoma and ocular hypertension.
Gugleta K
Curr Med Res Opin; 2010 Jun; 26(6):1255-67. PubMed ID: 20350146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
